{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:59:42Z","timestamp":1793051982702,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"abstract":"<jats:p>The aim is to explore the causal relationship between gluten-free diet and IgA nephropathy by conducting Mendelian randomization (MR) analysis and briefly summarizing the current research on gluten-free diet and IgA nephropathy to provide new insights for the prevention and treatment of IgA nephropathy. The 64,949 samples of gluten-free diet and 477,784 samples of IgA nephropathy were obtained from the genome-wide association study. Four genetic variants strongly associated with a gluten-free diet were extracted as instrumental variables. Two-sample MR analysis was performed by multiplicative random-effects inverse variance weighted, MR-Egger regression, weighted median, weighted mode, simple median, maximum likelihood ratio, and penalized weighted median as analysis models, respectively. Odds ratio values were used to evaluate the causal relationship between gluten-free diet and IgA nephropathy. The sensitivity analysis was carried out by the Cochran <jats:italic toggle=\"yes\">Q<\/jats:italic> test, MR-Pleiotropy RESidual Sum and Outlier test, MR-Egger intercept test, and leave-one-out analysis to assess the robustness of the results. Multiplicative random-effects inverse variance weighted analysis showed a significant negative correlation between gluten-free diet and IgA nephropathy (odds ratio\u2005=\u20052.333\u2005\u00d7\u200510<jats:sup>\u22124<\/jats:sup>, 95% confidence interval\u2005=\u20054.628\u2005\u00d7\u200510<jats:sup>\u22126<\/jats:sup>~1.176\u2005\u00d7\u200510<jats:sup>\u22122<\/jats:sup>, <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>=\u20052.899\u2005\u00d7\u200510<jats:sup>\u22125<\/jats:sup>). In conclusion, there might be a negative causal relationship between gluten-free diet and IgA nephropathy, which could potentially reduce the risk of IgA nephropathy.<\/jats:p>","DOI":"10.1097\/md.0000000000041964","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:02:24Z","timestamp":1750215744000},"page":"e41964","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between gluten-free diet and IgA nephropathy: A review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9688-4291","authenticated-orcid":false,"given":"Tianqi","family":"Pei","sequence":"first","affiliation":[{"name":"Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9740-4709","authenticated-orcid":false,"given":"Dengzhou","family":"Guo","sequence":"additional","affiliation":[{"name":"Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China"},{"name":"Hebei Technology Innovation Center of TCM Spleen and Kidney Diseases, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy.","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"1175088","DOI":"10.3389\/fneph.2023.1175088","article-title":"IgA nephropathy: a review of existing and emerging therapies.","volume":"3","author":"Noor","year":"2023","journal-title":"Front Nephrol"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1007\/s11255-023-03598-x","article-title":"Global trends and hotspots in IgA nephropathy: a bibliometric analysis and knowledge map visualization from 2012 to 2023.","volume":"55","author":"Wang","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature.","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","article-title":"IgA nephropathy: core curriculum 2021.","volume":"78","author":"Pattrapornpisut","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/ndt\/gfae034","article-title":"Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA registry.","volume":"39","author":"ElHafeez","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"R7-20250618","first-page":"694","article-title":"Intercapillary deposits of IgA-IgG.","volume":"74","author":"Berger","year":"1968","journal-title":"J Urol Nephrol (Paris)"},{"issue":"1 Suppl","key":"R8-20250618","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What is gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12876-020-01390-0","article-title":"An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects.","volume":"20","author":"Taraghikhah","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC202001070","article-title":"Celiac disease.","volume":"172","author":"Rubin","year":"2020","journal-title":"Ann Intern Med"},{"key":"R11-20250618","first-page":"39","article-title":"Celiac disease associated with immune complex glomerulonephritis.","volume":"11","author":"Katz","year":"1979","journal-title":"Clin Nephrol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000185033","article-title":"Levels of circulating IgA immune complexes after gluten-rich diet in patients with IgA nephropathy.","volume":"49","author":"Yagame","year":"1988","journal-title":"Nephron"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1126\/science.aax4588","article-title":"Translational genomics and precision medicine: moving from the lab to the clinic.","volume":"365","author":"Zeggini","year":"2019","journal-title":"Science"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/ije\/dyx275","article-title":"An introduction to instrumental variables for epidemiologists.","volume":"47","author":"Greenland","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R17-20250618","first-page":"244293","article-title":"The MRC IEU OpenGWAS data infrastructure. Cold Spring Harbor Laboratory 2020.","volume":"10","author":"Elsworth","year":"2020","journal-title":"bioRxiv"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Heman","year":"2017","journal-title":"PLoS Genet"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.joca.2021.12.001","article-title":"Assessing causality between osteoarthritis with urate levels and gout: a bidirectional Mendelian randomization study.","volume":"30","author":"Chen","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R25-20250618","first-page":"260","article-title":"May gluten free diet reduce the levels of IgA immune complexes in primary IgA nephropathy?","volume":"28","author":"Coppo","year":"1985","journal-title":"Kidney Int"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM198610303151819","article-title":"Dietary gluten and primary IgA nephropathy.","volume":"315","author":"Coppo","year":"1986","journal-title":"N Engl J Med"},{"key":"R27-20250618","first-page":"72","article-title":"Effects of a gluten-free diet in primary IgA nephropathy.","volume":"33","author":"Coppo","year":"1990","journal-title":"Clin Nephrol"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.295.6590.78","article-title":"IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger\u2019s disease).","volume":"295","author":"Fornasieri","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R29-20250618","first-page":"275","article-title":"Antibodies to dietary antigens in IgA nephropathy.","volume":"29","author":"Nagy","year":"1988","journal-title":"Clin Nephrol"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5414\/CNP74364","article-title":"Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy.","volume":"74","author":"Kloster Smerud","year":"2010","journal-title":"Clin Nephrol"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000167460","article-title":"An increase in circulating IgA antibodies to gliadin in IgA mesangial glomerulonephritis.","volume":"7","author":"Laurent","year":"1987","journal-title":"Am J Nephrol"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1084\/jem.157.2.572","article-title":"Experimental IgA nephropathy induced by oral immunization.","volume":"157","author":"Emancipator","year":"1983","journal-title":"J Exp Med"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(88)80038-6","article-title":"The pathogenetic potential of environmental antigens in IgA nephropathy.","volume":"12","author":"Coppo","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1681\/ASN.V210s173","article-title":"Dietary antigens and primary immunoglobulin A nephropathy.","volume":"2","author":"Coppo","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"R35-20250618","first-page":"499","article-title":"Gluten-induced experimental IgA glomerulopathy.","volume":"60","author":"Coppo","year":"1989","journal-title":"Lab Invest"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM198905113201918","article-title":"IgA antigliadin antibodies as a possible marker for IgA mesangial glomerulonephritis in adults with primary glomerulonephritis.","volume":"320","author":"Rostoker","year":"1989","journal-title":"N Engl J Med"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000013497","article-title":"IgA-antigliadin antibodies in patients with IgA nephropathy: the secondary phenomenon?","volume":"19","author":"Ots","year":"1999","journal-title":"Am J Nephrol"},{"key":"R38-20250618","first-page":"1382","article-title":"A case of IgA nephropathy with coeliac disease responding to a gluten-free diet.","volume":"8","author":"Woodrow","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0272-6386(12)80987-5","article-title":"Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production.","volume":"23","author":"Amore","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R40-20250618","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1681\/ASN.V210s149","article-title":"Macromolecular properties that promote mesangial binding and mesangiopathic nephritis.","volume":"2","author":"Emancipator","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"R41-20250618","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3748\/wjg.v9.i6.1377","article-title":"Multiple immune disorders in unrecognized celiac disease: a case report.","volume":"9","author":"La Villa","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R42-20250618","first-page":"161","article-title":"A case report: a patient with IgA nephropathy and coeliac disease. Complete clinical remission following gluten-free diet.","volume":"2","author":"Koivuviita","year":"2009","journal-title":"NDT Plus"},{"key":"R43-20250618","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/ndt\/gfp133","article-title":"Gluten sensitivity in patients with IgA nephropathy.","volume":"24","author":"Smerud","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R44-20250618","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/nu13051594","article-title":"Celiac disease-type tissue transglutaminase autoantibody deposits in kidney biopsies of patients with IgA nephropathy.","volume":"13","author":"Nurmi","year":"2021","journal-title":"Nutrients"},{"key":"R45-20250618","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12876-018-0792-0","article-title":"Case report on pathogenetic link between gluten and IgA nephropathy.","volume":"18","author":"Costa","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"R46-20250618","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ki.2015.94","article-title":"Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.","volume":"88","author":"Papista","year":"2015","journal-title":"Kidney Int"},{"key":"R47-20250618","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrneph.2015.53","article-title":"Glomerular disease: exacerbation of IgAN by gluten.","volume":"11","author":"Allison","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R48-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2020.02.019","article-title":"Food antigens and transglutaminase 2 in IgA nephropathy: molecular links between gut and kidney.","volume":"121","author":"Abbad","year":"2020","journal-title":"Mol Immunol"},{"key":"R49-20250618","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5114\/ceji.2019.84021","article-title":"IgA nephropathy associated with coeliac disease.","volume":"44","author":"Habura","year":"2019","journal-title":"Cent Eur J Immunol"},{"key":"R50-20250618","doi-asserted-by":"crossref","first-page":"e2021051332","DOI":"10.1542\/peds.2021-051332","article-title":"IgA nephropathy as the initial presentation of celiac disease in an adolescent.","volume":"148","author":"Slavin","year":"2021","journal-title":"Pediatrics"},{"key":"R51-20250618","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy.","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"R52-20250618","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.0000000000000242","article-title":"Treatment of IgA nephropathy: a rapidly evolving field.","volume":"35","author":"El Karoui","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"R53-20250618","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy.","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin Immunopathol"},{"key":"R54-20250618","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"key":"R55-20250618","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(86)92972-7","article-title":"Apolipoprotein E isoforms, serum cholesterol, and cancer.","volume":"1","author":"Katan","year":"1986","journal-title":"Lancet"},{"key":"R56-20250618","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.3390\/nu15184013","article-title":"The gluten-free diet for celiac disease: critical insights to better understand clinical outcomes.","volume":"15","author":"Sim\u00f3n","year":"2023","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:02:35Z","timestamp":1750215755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":56,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041964","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}